SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Short Candidates
An SI Board Since December 2000
Posts SubjectMarks Bans
897 95 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
322<< But isn't the zetia/zocor combo the strategy for extending ZocorSpekulatius-1/17/2003
321Thanks, Peter, That echoes rkrw's comment. This is the sort of participatituck-1/16/2003
320ALKS. They set the conversion bar for the restructured debt low with the goal torkrw-1/15/2003
319ALKS & NKTR I am still not high on ALKS since they still have debt around thSpekulatius-1/15/2003
318tuck, <i>This should also be bad for ENZN, but it is holding up. Have invBiomaven-1/15/2003
317I'm not sure the FDA is much kinder yet. They have always cut some slack foMichael Young-1/15/2003
316Tuck, I'm not particularly high on alks but I think there's a good chanrkrw-1/15/2003
315Aviron wannabe IDBE spiking: >>1:42PM ID Biomedical rises on news of misstuck-1/15/2003
314Thanks, rkrw, Speaking of INHL, they seem to be changing their name, which Petetuck-1/15/2003
313Peg-intron accounts for virtually all of enzn's profits. Note enzn will get rkrw-1/14/2003
312Hi Tuck, Good thinking. I do not know what part of their revenues relate to PeIRWIN JAMES FRANKEL-1/14/2003
311This should also be bad for ENZN, but it is holding up. Have investors not conntuck-1/14/2003
310Related to the ICN/RNA idea: 09:29 ET SGP Schering-Plough estimate cut at JP MoIRWIN JAMES FRANKEL-1/14/2003
309Thanks, IJ, That's worth exploring. Cheers, Tucktuck-1/13/2003
308RNA and ICN look like shorts after the Roche news: Message 18439424 - A 43% cuIRWIN JAMES FRANKEL-1/13/2003
307Genzyme Molecular Oncology Announces Positive Clinical Data from Melanoma CancerExtra Pale-1/12/2003
306Hmmm, this actually looks pretty good; has anyone else gotten complete responsestuck-1/12/2003
305Spek-- But isn't the zetia/zocor combo the strategy for extending Zocor'keokalani'nui-1/11/2003
304Short ideas? Not a biotech but i do consider MRK a better short than long at hisSpekulatius-1/11/2003
303Shart ideas? Not a biotech but i do consider MRK a better short than long at hisSpekulatius-1/11/2003
302January 20s, I managed .05 better than the .55 bid that was showing (tried for .tuck-1/10/2003
301Would you mind discussing how much of the spread you managed to nibble off the tLondo-1/10/2003
300Disclosure: just shorted some VXGN calls circa $19.2. Cheers, Tucktuck-1/10/2003
299First person I thought of when I saw this PR was you, Tuck. About VXGN: That PLondo-1/9/2003
298Double dang! >>Wednesday January 8, 4:15 pm ET NEW YORK--(BUSINESS WIREtuck-1/8/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News